14-Ethyl-2,5,11-trimethyl-4,13,19,20-tetraoxa-tricyclo[14.2.1.1(7,10)]
eicosane-3,12-dione (MFTZ-1), a new
macrolide compound isolated from Streptomyces sp. Is9131, displayed wide cytotoxicity in human tumor cell lines with an average IC(50) of 0.905 micromol/L. Notably,
MFTZ-1 showed significant cytotoxicity in the three multidrug resistance cell lines with an average resistance factor of 2.08. The in vivo experiments showed that
MFTZ-1 had inhibitory effects on the human ovarian
carcinoma HO-8910 cell line xenotransplanted in nude mice. Further studies showed that
MFTZ-1 induced
DNA double-strand breaks and triggered mitochondria-dependent apoptosis in human
leukemia HL-60 cells. Using a yeast genetic system, we found that topoisomerase (
Topo) II rather than
Topo I was the primary cellular target of
MFTZ-1. Most importantly,
MFTZ-1 functions as a novel nonintercalative
Topo II
poison via binding to
ATPase of
Topo II, characterized by its strong inhibition on the decatenation and relaxation of
Topo II. The capacity of
MFTZ-1 to stabilize
Topo II-
DNA covalent complexes was comparable with that of the classic
Topo II
poison,
etoposide. Moreover, using a
Topo II catalytic inhibitor
aclarubicin and
Topo II-deficient HL-60/MX2 cells, we further showed that MFTZ-1-triggered
DNA double-strand breaks and apoptosis occurred in a
Topo II-dependent manner. Together, the well-defined
Topo II-
poisoning function and the potent antitumor activity, with the appreciable anti-multidrug resistance action in particular, promises
MFTZ-1 as a novel potential
Topo II-targeted agent, which merits further research and development.